Today: 7 October 2025
17 June 2021
2 mins read

Abu Dhabi receives new anti-Covid medication

With the arrival of the first shipment yesterday at Abu Dhabi airport, Abu Dhabi becomes the first city in the world to receive this drug….reports Asian Lite News

The world’s newest anti-viral treatment for COVID-19, Sotrovimab, is now available for early treatment of certain categories of COVID-19 patients in the UAE.

This was following a landmark agreement between the Department of Health – Abu Dhabi, leading Group Purchasing Organisation (GPO), Rafed, and global innovative biopharmaceutical company, GlaxoSmithKline (GSK).

With the arrival of the first shipment yesterday at Abu Dhabi airport, Abu Dhabi becomes the first city in the world to receive this drug.

Sotrovimab is a monoclonal antibody treatment delivered through intravenous therapy. Sotrovimab can be used to treat adults and children above the age of 12 who meet certain criteria and are at risk of progressing to severe COVID-19, as per protocols that have been developed by the National Scientific Committee.

Studies have shown the medicine to prevent hospitalisation and death in 85% of early selected treatment cases and can work on all known variations to date.

Following US Food and Drug Administration’s emergency use authorisation, the UAE Ministry of Health and Prevention issued its endorsement of the new GSK medicine following a national assessment.

The agreement is to ensure deliveries as early as June and July, enabling patients in the UAE to be among the first in the world to access the new therapy.

Abu Dhabi-based Rafed will facilitate the procurement, storage and distribution of Sotrovimab via the Rafed Distribution Center – the region’s largest specialised cold-storage facility.

Dr. Jamal Mohamed Kaabi, Undersecretary for the Department of Health- Abu Dhabi, said: “This medicine is at the forefront of pharmaceutical advancement and is a powerful tool in our fight to end this pandemic. We are looking forward to implementing the eligibility criteria for emergency use of Sotrovimab as part of Abu Dhabi’s commitment to lead an all-encompassing COVID -19 response in prevention, treatment and care.”

Rashed Al Qubaisi, CEO of Rafed said: “Sotrovimab represents a massive breakthrough in the fight against COVID-19. Through our close collaboration and partnership with the Department of Health and GSK, we have been able to work swiftly in the procurement of the medication to ensure an effective and timely roll-out across the UAE.”

ALSO READ: Scanners to detect potential Covid-19 cases in Abu Dhabi

Previous Story

Expo, UN Global Compact to organise sustainability forum

Next Story

Arab League warns against Lebanon political crisis

Latest from -Top News

OCTOBER 7: Stop the Violence Now, Says Guterres

Guterres recalled that “the attackers brutally killed more than 1,250 Israelis and foreign nationals….reports Asian Lite News UN Secretary-General Antonio Guterres urged an immediate halt to the violence in Gaza, Israel, and

Piyush Goyal Heads to Doha for Trade Talks

During the visit, both sides are expected to discuss the proposed India–Qatar Free Trade Agreement (FTA)….reports Asian Lite News Union Commerce and Industry Minister Piyush Goyal will travel to Doha, Qatar, on

Hamas Heads to Egypt for Gaza Talks

The negotiation will focus on the details of enacting the first phase of the plan…reports Asian Lite News A delegation from the Palestinian group Hamas arrived in Egypt on Sunday ahead of

Multi-alignment, upgraded

With US ties strained and China tense, New Delhi taps Europe’s harder edge for co-development, clean tech and strategic autonomy, writes Manoj Menon India is recalibrating its great-power hedging as frictions with
Go toTop

Don't Miss

UAE and ICRC sign deal for Red Cross office in Abu Dhabi

Al Hashemy underscored that the UAE always seeks to enhance

Q1: Dh13.8b in new savings deposits in banking sector

The apex bank’s statistics showed that savings deposits in the